| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.909 | 0.005 | 0.919 | Antiinflammatory | 0.919 0.005 CID_154699865 | CID_154699865 | |
| 0.822 | 0.014 | 0.829 | Apoptosis agonist | 0.829 0.013 CID_154699865 | CID_154699865 | |
| 0.734 | 0.005 | 0.763 | Nitric oxide antagonist | 0.763 0.005 CID_154699865 | CID_154699865 | |
| 0.675 | 0.005 | 0.735 | Tumour necrosis factor alpha release inhibitor | 0.735 0.005 CID_154699865 | CID_154699865 | |
| 0.637 | 0.009 | 0.637 | Immunosuppressant | 0.633 0.009 CID_154699865 | ||
| 0.62 | 0.005 | 0.62 | P-glycoprotein inhibitor | 0.485 0.009 CID_154699865 | ||
| 0.576 | 0.002 | 0.576 | Lipocortins synthesis antagonist | 0.386 0.01 CID_154699865 | ||
| 0.566 | 0.042 | 0.566 | Caspase 9 stimulant | 0.551 0.044 CID_154699865 | ||
| 0.538 | 0.039 | 0.808 | Transcription factor NF kappa B inhibitor | 0.808 0.012 CID_154699865 | CID_154699865 | |
| 0.479 | 0.005 | 0.479 | Sodium/bile acid cotransporter inhibitor | 0.307 0.073 CID_154699865 | ||
| 0.476 | 0.007 | 0.532 | Interferon gamma antagonist | 0.532 0.004 CID_154699865 | CID_154699865 | |
| 0.472 | 0.024 | 0.631 | Apoptosis antagonist | 0.631 0.007 CID_154699865 | CID_154699865 | |
| 0.443 | 0.042 | 0.644 | Cholesterol antagonist | 0.644 0.013 CID_154699865 | CID_154699865 | |
| 0.403 | 0.034 | 0.665 | Antioxidant | 0.665 0.007 CID_154699865 | CID_154699865 | |
| 0.371 | 0.02 | 0.371 | Growth hormone agonist | |||
| 0.397 | 0.046 | 0.433 | 5 Hydroxytryptamine release stimulant | 0.433 0.039 CID_154699865 | CID_154699865 | |
| 0.388 | 0.049 | 0.388 | Aldehyde oxidase inhibitor | |||
| 0.356 | 0.024 | 0.356 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.346 | 0.031 | 0.456 | DNA synthesis inhibitor | 0.456 0.017 CID_154699865 | CID_154699865 | |
| 0.335 | 0.021 | 0.565 | Hepatoprotectant | 0.565 0.005 CID_154699865 | CID_154699865 | |
| 0.324 | 0.017 | 0.324 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.166 0.114 CID_154699865 | ||
| 0.317 | 0.01 | 0.317 | Cholesterol synthesis inhibitor | 0.249 0.018 CID_154699865 | ||
| 0.369 | 0.066 | 0.369 | Vasodilator, peripheral | 0.282 0.107 CID_154699865 | ||
| 0.385 | 0.088 | 0.452 | 5 Hydroxytryptamine release inhibitor | 0.452 0.051 CID_154699865 | CID_154699865 | |
| 0.345 | 0.053 | 0.345 | Calcium channel activator | |||
| 0.333 | 0.042 | 0.637 | Hypoglycemic | 0.637 0.006 CID_154699865 | CID_154699865 | |
| 0.303 | 0.016 | 0.344 | Alpha-N-acetylglucosaminidase inhibitor | 0.344 0.012 CID_154699865 | CID_154699865 | |
| 0.276 | 0.003 | 0.276 | Adenylate cyclase stimulant | 0.188 0.02 CID_154699865 | ||
| 0.27 | 0.003 | 0.27 | Arachidonic acid antagonist | 0.203 0.03 CID_154699865 | ||
| 0.321 | 0.056 | 0.321 | Hypoxia-inducible factor 1 alpha inhibitor | 0.273 0.081 CID_154699865 | ||
| 0.292 | 0.039 | 0.292 | Gastrin inhibitor | 0.222 0.115 CID_154699865 | ||
| 0.3 | 0.049 | 0.753 | Angiogenesis stimulant | 0.753 0.004 CID_154699865 | CID_154699865 | |
| 0.25 | 0.009 | 0.254 | Microtubule formation inhibitor | 0.254 0.008 CID_154699865 | CID_154699865 | |
| 0.26 | 0.022 | 0.26 | Antipruritic | 0.147 0.098 CID_154699865 | ||
| 0.274 | 0.041 | 0.3 | Anesthetic general | 0.3 0.033 CID_154699865 | CID_154699865 | |
| 0.257 | 0.025 | 0.323 | Protein kinase stimulant | 0.323 0.014 CID_154699865 | CID_154699865 | |
| 0.308 | 0.076 | 0.565 | Immunostimulant | 0.565 0.021 CID_154699865 | CID_154699865 | |
| 0.236 | 0.007 | 0.309 | Transcription factor NF kappa B stimulant | 0.309 0.004 CID_154699865 | CID_154699865 | |
| 0.228 | 0.021 | 0.228 | Adenylate cyclase inhibitor | 0.123 0.065 CID_154699865 | ||
| 0.231 | 0.032 | 0.37 | Melanin inhibitor | 0.37 0.014 CID_154699865 | CID_154699865 | |
| 0.203 | 0.004 | 0.203 | Anabolic | 0.139 0.024 CID_154699865 | ||
| 0.284 | 0.086 | 0.433 | Interleukin 2 agonist | 0.433 0.019 CID_154699865 | CID_154699865 | |
| 0.248 | 0.05 | 0.248 | RNA-directed DNA polymerase inhibitor | 0.236 0.059 CID_154699865 | ||
| 0.24 | 0.045 | 0.24 | Neurotrophic factor enhancer | 0.219 0.059 CID_154699865 | ||
| 0.203 | 0.013 | 0.203 | Antineoplastic alkaloid | |||
| 0.2 | 0.014 | 0.2 | Androgen antagonist | |||
| 0.259 | 0.076 | 0.259 | Transcription factor STAT3 inhibitor | |||
| 0.254 | 0.072 | 0.254 | Superoxide dismutase inhibitor | |||
| 0.25 | 0.069 | 0.407 | Vasodilator | 0.407 0.022 CID_154699865 | CID_154699865 | |
| 0.206 | 0.026 | 0.206 | DNA polymerase I inhibitor | 0.2 0.028 CID_154699865 | ||
| 0.281 | 0.102 | 0.662 | Antithrombotic | 0.662 0.01 CID_154699865 | CID_154699865 | |
| 0.181 | 0.005 | 0.181 | Androgen agonist | |||
| 0.211 | 0.038 | 0.211 | Phospholipase C inhibitor | 0.138 0.132 CID_154699865 | ||
| 0.304 | 0.133 | 0.632 | Antibacterial | 0.632 0.015 CID_154699865 | CID_154699865 | |
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.175 0.01 CID_154699865 | ||
| 0.188 | 0.023 | 0.338 | Antineoplastic antibiotic | 0.338 0.008 CID_154699865 | CID_154699865 | |
| 0.198 | 0.036 | 0.198 | Bone formation stimulant | 0.144 0.064 CID_154699865 | ||
| 0.18 | 0.019 | 0.18 | Pregnane X receptor agonist | |||
| 0.216 | 0.058 | 0.216 | Insulin sensitizer | 0.154 0.128 CID_154699865 | ||
| 0.16 | 0.005 | 0.16 | Aldosterone antagonist | |||
| 0.173 | 0.027 | 0.383 | Expectorant | 0.383 0.005 CID_154699865 | CID_154699865 | |
| 0.147 | 0.006 | 0.159 | Na+ K+ transporting ATPase inhibitor | 0.159 0.004 CID_154699865 | CID_154699865 | |
| 0.142 | 0.003 | 0.142 | Heme oxygenase stimulant | 0.1 0.007 CID_154699865 | ||
| 0.147 | 0.008 | 0.147 | Glycine receptor antagonist | 0.143 0.009 CID_154699865 | ||
| 0.163 | 0.025 | 0.287 | UDP-glucose 4-epimerase inhibitor | 0.287 0.011 CID_154699865 | CID_154699865 | |
| 0.191 | 0.057 | 0.191 | Succinate dehydrogenase inhibitor | |||
| 0.136 | 0.002 | 0.136 | Lipocortins synthesis agonist | 0.104 0.005 CID_154699865 | ||
| 0.137 | 0.004 | 0.137 | Glucocorticoid antagonist | 0.032 0.023 CID_154699865 | ||
| 0.272 | 0.14 | 0.521 | Histamine release inhibitor | 0.521 0.022 CID_154699865 | CID_154699865 | |
| 0.136 | 0.007 | 0.136 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.224 | 0.099 | 0.371 | Interleukin agonist | 0.371 0.024 CID_154699865 | CID_154699865 | |
| 0.228 | 0.104 | 0.228 | Transcription factor STAT inhibitor | |||
| 0.315 | 0.192 | 0.315 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.159 | 0.043 | 0.159 | Farnesoid X receptor antagonist | |||
| 0.143 | 0.029 | 0.157 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.157 0.024 CID_154699865 | CID_154699865 | |
| 0.166 | 0.052 | 0.166 | CF transmembrane conductance regulator agonist | |||
| 0.142 | 0.029 | 0.142 | Adenylate kinase inhibitor | |||
| 0.135 | 0.022 | 0.135 | ABCA1 expression enhancer | |||
| 0.189 | 0.077 | 0.392 | Platelet adhesion inhibitor | 0.392 0.012 CID_154699865 | CID_154699865 | |
| 0.119 | 0.008 | 0.119 | 5-Alpha-reductase inhibitor | |||
| 0.122 | 0.012 | 0.122 | Glycine receptor agonist | 0.112 0.015 CID_154699865 | ||
| 0.235 | 0.126 | 0.289 | Caspase 3 stimulant | 0.289 0.085 CID_154699865 | CID_154699865 | |
| 0.138 | 0.03 | 0.138 | Estrogen antagonist | |||
| 0.127 | 0.019 | 0.127 | Keratolytic | |||
| 0.112 | 0.004 | 0.112 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.071 0.006 CID_154699865 | ||
| 0.111 | 0.004 | 0.111 | Adenylate cyclase 1 inhibitor | |||
| 0.129 | 0.023 | 0.223 | Phosphofructokinase-1 inhibitor | 0.223 0.009 CID_154699865 | CID_154699865 | |
| 0.123 | 0.018 | 0.123 | Estrogen receptor alpha antagonist | |||
| 0.244 | 0.14 | 0.387 | Vasodilator, coronary | 0.387 0.04 CID_154699865 | CID_154699865 | |
| 0.14 | 0.039 | 0.173 | CC chemokine 6 receptor antagonist | 0.173 0.007 CID_154699865 | CID_154699865 | |
| 0.127 | 0.029 | 0.185 | Triose-phosphate isomerase inhibitor | 0.185 0.013 CID_154699865 | CID_154699865 | |
| 0.28 | 0.181 | 0.722 | Cyclophilin D inhibitor | 0.722 0.012 CID_154699865 | CID_154699865 | |
| 0.211 | 0.117 | 0.211 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.134 | 0.041 | 0.134 | GABA C receptor agonist | |||
| 0.096 | 0.004 | 0.096 | Farnesoid X receptor agonist | |||
| 0.192 | 0.103 | 0.192 | Nitric-oxide synthase stimulant | 0.19 0.106 CID_154699865 | ||
| 0.091 | 0.003 | 0.091 | Glucocorticoid agonist | |||
| 0.103 | 0.016 | 0.103 | Estrogen agonist | 0.068 0.027 CID_154699865 | ||
| 0.112 | 0.028 | 0.145 | Glutamate release inhibitor | 0.145 0.011 CID_154699865 | CID_154699865 | |
| 0.126 | 0.044 | 0.204 | AMP-activated protein kinase stimulant | 0.204 0.01 CID_154699865 | CID_154699865 | |
| 0.114 | 0.032 | 0.164 | NADH dehydrogenase inhibitor | 0.164 0.015 CID_154699865 | CID_154699865 | |
| 0.094 | 0.013 | 0.094 | Glutamate (mGluR6) antagonist | |||
| 0.127 | 0.048 | 0.129 | Mucolytic | 0.129 0.047 CID_154699865 | CID_154699865 | |
| 0.098 | 0.019 | 0.098 | Alcohol oxidase inhibitor | |||
| 0.088 | 0.009 | 0.121 | Alpha-mannosidase inhibitor | 0.121 0.005 CID_154699865 | CID_154699865 | |
| 0.148 | 0.069 | 0.268 | Lipid peroxidase inhibitor | 0.268 0.024 CID_154699865 | CID_154699865 | |
| 0.11 | 0.031 | 0.11 | Bile acid receptor antagonist | |||
| 0.115 | 0.039 | 0.115 | Estrogen receptor beta antagonist | |||
| 0.082 | 0.008 | 0.082 | RNA-directed RNA polymerase stimulant | 0.035 0.019 CID_154699865 | ||
| 0.188 | 0.116 | 0.418 | Peptidyltransferase inhibitor | 0.418 0.006 CID_154699865 | CID_154699865 | |
| 0.107 | 0.034 | 0.107 | Interleukin 5 antagonist | 0.092 0.052 CID_154699865 | ||
| 0.083 | 0.011 | 0.083 | Estrogen receptor alpha agonist | |||
| 0.087 | 0.016 | 0.087 | Nitric oxide donor | 0.086 0.017 CID_154699865 | ||
| 0.07 | 0.002 | 0.07 | Corticosteroid-like | 0.037 0.004 CID_154699865 | ||
| 0.096 | 0.03 | 0.096 | Estrogen-related receptor beta agonist | |||
| 0.079 | 0.012 | 0.079 | Oxytocin antagonist | |||
| 0.081 | 0.014 | 0.081 | Estrogen receptor beta agonist | |||
| 0.075 | 0.009 | 0.075 | Pregnane X receptor antagonist | |||
| 0.124 | 0.059 | 0.326 | Monophenol monooxygenase inhibitor | 0.326 0.015 CID_154699865 | CID_154699865 | |
| 0.234 | 0.169 | 0.234 | GABA C receptor rho-3 antagonist | |||
| 0.089 | 0.024 | 0.089 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.087 | 0.023 | 0.087 | Argininosuccinate synthase inhibitor | |||
| 0.105 | 0.043 | 0.105 | Potassium channel activator | |||
| 0.117 | 0.055 | 0.117 | GABA C receptor antagonist | |||
| 0.107 | 0.046 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.077 | 0.018 | 0.077 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.071 | 0.012 | 0.071 | Progesterone antagonist | |||
| 0.097 | 0.039 | 0.097 | Inducible nitric-oxide synthase inhibitor | |||
| 0.069 | 0.012 | 0.105 | Mannosidase inhibitor | 0.105 0.005 CID_154699865 | CID_154699865 | |
| 0.065 | 0.008 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 CID_154699865 | CID_154699865 | |
| 0.057 | 0.001 | 0.082 | Telomerase stimulant | 0.082 0.001 CID_154699865 | CID_154699865 | |
| 0.069 | 0.013 | 0.079 | Glucose-6-phosphate isomerase inhibitor | 0.079 0.009 CID_154699865 | CID_154699865 | |
| 0.065 | 0.01 | 0.065 | Vasopressin 2 antagonist | |||
| 0.116 | 0.062 | 0.155 | Photosensitizer | 0.155 0.028 CID_154699865 | CID_154699865 | |
| 0.064 | 0.01 | 0.064 | Microtubule stabilization | 0.062 0.012 CID_154699865 | ||
| 0.058 | 0.005 | 0.058 | Tubulin agonist | 0.038 0.017 CID_154699865 | ||
| 0.106 | 0.053 | 0.106 | Creatine kinase inhibitor | |||
| 0.126 | 0.074 | 0.126 | Vanilloid 1 agonist | 0.126 0.073 CID_154699865 | ||
| 0.096 | 0.048 | 0.096 | Ornithine decarboxylase inhibitor | |||
| 0.077 | 0.029 | 0.077 | Aromatase inhibitor | |||
| 0.122 | 0.075 | 0.271 | Cyclooxygenase 3 inhibitor | 0.271 0.007 CID_154699865 | CID_154699865 | |
| 0.112 | 0.065 | 0.112 | Cystathionine beta-synthase inhibitor | |||
| 0.086 | 0.039 | 0.086 | Glutamate dehydrogenase inhibitor | |||
| 0.083 | 0.04 | 0.083 | CDC25A inhibitor | |||
| 0.062 | 0.019 | 0.062 | Potassium channel Kv1.3 blocker | |||
| 0.067 | 0.029 | 0.067 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.041 | 0.004 | 0.041 | Hedgehog signaling activator | |||
| 0.078 | 0.044 | 0.078 | Vanilloid 4 agonist | |||
| 0.042 | 0.009 | 0.042 | Glutamate (mGluR3) agonist | |||
| 0.128 | 0.096 | 0.189 | Diuretic | 0.189 0.049 CID_154699865 | CID_154699865 | |
| 0.054 | 0.023 | 0.054 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.046 | 0.015 | 0.046 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.064 | 0.033 | 0.064 | Sphingosine kinase inhibitor | |||
| 0.088 | 0.064 | 0.096 | Thioredoxin inhibitor | 0.096 0.053 CID_154699865 | CID_154699865 | |
| 0.048 | 0.025 | 0.048 | Parathyroid hormone antagonist | |||
| 0.043 | 0.024 | 0.043 | Kainate receptor agonist | |||
| 0.125 | 0.106 | 0.262 | NOS3 expression enhancer | 0.262 0.024 CID_154699865 | CID_154699865 | |
| 0.057 | 0.038 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.022 | 0.004 | 0.022 | Thromboxane agonist | |||
| 0.029 | 0.011 | 0.046 | Vanilloid 2 agonist | 0.046 0.003 CID_154699865 | CID_154699865 | |
| 0.027 | 0.01 | 0.027 | Prostaglandin F2 alpha agonist | |||
| 0.131 | 0.115 | 0.131 | Heat shock protein 70 antagonist | |||
| 0.104 | 0.088 | 0.104 | Interleukin 8 antagonist | |||
| 0.021 | 0.005 | 0.021 | Thromboxane A2 agonist | |||
| 0.025 | 0.01 | 0.025 | Vitamin D receptor antagonist | 0.021 0.018 CID_154699865 | ||
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.032 | 0.018 | 0.032 | Vasopressin 1A antagonist | |||
| 0.023 | 0.009 | 0.023 | Progesterone agonist | |||
| 0.046 | 0.033 | 0.062 | Phosphorylase inhibitor | 0.062 0.024 CID_154699865 | CID_154699865 | |
| 0.047 | 0.034 | 0.047 | Mineralocorticoid receptor antagonist | |||
| 0.1 | 0.088 | 0.21 | Alkylator | 0.21 0.024 CID_154699865 | CID_154699865 | |
| 0.03 | 0.018 | 0.03 | Purinergic P2X agonist | |||
| 0.014 | 0.002 | 0.014 | Transcortin receptor antagonist | |||
| 0.053 | 0.042 | 0.053 | Sphingosine kinase 2 inhibitor | |||
| 0.036 | 0.025 | 0.036 | Ceramide glucosyltransferase inhibitor | |||
| 0.024 | 0.015 | 0.024 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.04 | 0.031 | 0.04 | Sphingosine kinase 1 inhibitor | |||
| 0.022 | 0.013 | 0.022 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.031 | 0.023 | 0.031 | ATP citrate lysase inhibitor | |||
| 0.031 | 0.023 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.016 | 0.008 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | |||
| 0.036 | 0.03 | 0.036 | Glutamate (mGluR8) agonist | |||
| 0.094 | 0.088 | 0.094 | DOPA decarboxylase inhibitor | |||
| 0.056 | 0.05 | 0.056 | Purinergic P2X1 antagonist | |||
| 0.054 | 0.048 | 0.054 | Botulinum neurotoxin type A inhibitor | |||
| 0.021 | 0.014 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.019 | 0.013 | 0.019 | 5-Alpha-reductase 2 inhibitor | |||
| 0.041 | 0.036 | 0.041 | Heme oxygenase inhibitor | |||
| 0.073 | 0.067 | 0.073 | Carbonic anhydrase VI inhibitor | |||
| 0.019 | 0.014 | 0.033 | Antibiotic Anthracycline-like | 0.033 0.003 CID_154699865 | CID_154699865 | |
| 0.037 | 0.032 | 0.037 | Vanilloid 3 antagonist | |||
| 0.019 | 0.014 | 0.019 | Progesterone receptor B antagonist | |||
| 0.034 | 0.03 | 0.034 | Glutamate (mGluR3) antagonist | |||
| 0.032 | 0.028 | 0.032 | HMG CoA reductase inhibitor | |||
| 0.091 | 0.088 | 0.113 | Protein-tyrosine phosphatase 1B inhibitor | 0.113 0.068 CID_154699865 | CID_154699865 | |
| 0.053 | 0.049 | 0.053 | Biliverdin reductase inhibitor | |||
| 0.022 | 0.019 | 0.075 | Protein 30S ribosomal subunit inhibitor | 0.075 0.004 CID_154699865 | CID_154699865 | |
| 0.066 | 0.063 | 0.066 | Phospholipase D inhibitor | |||
| 0.03 | 0.029 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.096 | 0.095 | 0.096 | TRPA1 agonist | |||
| 0.015 | 0.014 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_154699865 | CID_154699865 | |
| 0.148 | 0.147 | 0.47 | Free radical scavenger | 0.47 0.019 CID_154699865 | CID_154699865 | |
| 0.098 | 0.098 | 0.293 | Amylase inhibitor | 0.293 0.019 CID_154699865 | CID_154699865 | |
| 0.128 | 0.129 | 0.187 | Interleukin 6 antagonist | 0.187 0.049 CID_154699865 | CID_154699865 | |
| 0.131 | 0.134 | 0.143 | Psychostimulant | 0.143 0.122 CID_154699865 | CID_154699865 | |
| 0.043 | 0.049 | 0.137 | Protein 50S ribosomal subunit inhibitor | 0.137 0.008 CID_154699865 | CID_154699865 | |
| 0.029 | 0.043 | 0.087 | Antibiotic Aminoglycoside-like | 0.087 0.004 CID_154699865 | CID_154699865 | |
| 0.022 | 0.042 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 CID_154699865 | CID_154699865 | |
| 0.003 | 0.034 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 CID_154699865 | CID_154699865 | |
| 0.016 | 0.05 | 0.036 | Sodium/glucose cotransporter 2 inhibitor | 0.036 0.01 CID_154699865 | CID_154699865 | |
| 0.016 | 0.052 | 0.047 | Arginase inhibitor | 0.047 0.017 CID_154699865 | CID_154699865 | |
| 0.017 | 0.056 | 0.032 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 CID_154699865 | CID_154699865 | |
| 0.126 | 0.166 | 0.227 | Hypolipemic | 0.227 0.079 CID_154699865 | CID_154699865 | |
| 0.077 | 0.12 | 0.134 | Beta glucuronidase inhibitor | 0.134 0.034 CID_154699865 | CID_154699865 | |
| 0.111 | 0.201 | 0.206 | ATPase inhibitor | 0.206 0.033 CID_154699865 | CID_154699865 | |
| 0.089 | 0.187 | 0.171 | Hexokinase inhibitor | 0.171 0.057 CID_154699865 | CID_154699865 | |
| 0.03 | 0.135 | 0.081 | Glucose-6-phosphate translocase inhibitor | 0.081 0.011 CID_154699865 | CID_154699865 | |
| 0.03 | 0.137 | 0.085 | Heparanase inhibitor | 0.085 0.005 CID_154699865 | CID_154699865 | |
| 0.117 | 0.226 | 0.184 | Cyclic AMP phosphodiesterase inhibitor | 0.184 0.107 CID_154699865 | CID_154699865 | |
| 0.051 | 0.173 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.104 0.034 CID_154699865 | CID_154699865 | |
| 0.035 | 0.16 | 0.185 | Topoisomerase II alpha inhibitor | 0.185 0.017 CID_154699865 | CID_154699865 | |
| 0.036 | 0.163 | 0.114 | Histone deacetylase stimulant | 0.114 0.02 CID_154699865 | CID_154699865 | |
| 0.036 | 0.163 | 0.114 | Histone deacetylase SIRT1 stimulant | 0.114 0.02 CID_154699865 | CID_154699865 | |
| 0.097 | 0.224 | 0.265 | Non-steroidal antiinflammatory agent | 0.265 0.037 CID_154699865 | CID_154699865 | |
| 0.064 | 0.226 | 0.118 | Interleukin 4 antagonist | 0.118 0.089 CID_154699865 | CID_154699865 | |
| 0.018 | 0.181 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.045 0.033 CID_154699865 | CID_154699865 | |
| 0.079 | 0.243 | 0.15 | DNA repair enzyme inhibitor | 0.15 0.031 CID_154699865 | CID_154699865 | |
| 0.02 | 0.184 | 0.339 | Selectin antagonist | 0.339 0.004 CID_154699865 | CID_154699865 | |
| 0.055 | 0.225 | 0.147 | Toll-Like receptor 4 antagonist | 0.147 0.023 CID_154699865 | CID_154699865 | |
| 0.069 | 0.242 | 0.207 | Cell wall synthesis inhibitor | 0.207 0.027 CID_154699865 | CID_154699865 | |
| 0.032 | 0.219 | 0.197 | Topoisomerase I inhibitor | 0.197 0.027 CID_154699865 | CID_154699865 | |
| 0.015 | 0.207 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.008 CID_154699865 | CID_154699865 | |
| 0.032 | 0.228 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.026 CID_154699865 | CID_154699865 | |
| 0.103 | 0.324 | 0.228 | Alpha-glucosidase inhibitor | 0.228 0.201 CID_154699865 | CID_154699865 | |
| 0.033 | 0.263 | 0.252 | Topoisomerase II inhibitor | 0.252 0.024 CID_154699865 | CID_154699865 | |
| 0.065 | 0.328 | 0.184 | Hemostatic | 0.184 0.04 CID_154699865 | CID_154699865 | |
| 0.017 | 0.284 | 0.063 | Neuraminidase (influenza) inhibitor | 0.063 0.047 CID_154699865 | CID_154699865 | |
| 0.032 | 0.343 | 0.311 | Thrombolytic | 0.311 0.022 CID_154699865 | CID_154699865 | |
| 0.045 | 0.392 | 0.241 | Platelet antagonist | 0.241 0.077 CID_154699865 | CID_154699865 | |
| 0.04 | 0.47 | 0.2 | Insulin secretagoues | 0.2 0.036 CID_154699865 | CID_154699865 | |
| 0.005 | 0.452 | 0.023 | Motilin receptor agonist | 0.023 0.015 CID_154699865 | CID_154699865 | |
| 0.025 | 0.536 | 0.223 | Cell adhesion inhibitor | 0.223 0.019 CID_154699865 | CID_154699865 | |
| 0.038 | 0.653 | 0.317 | Immunomodulator | 0.317 0.073 CID_154699865 | CID_154699865 | |
| 0.01 | 0.877 | 0.058 | Factor IXa inhibitor | 0.058 0.028 CID_154699865 | CID_154699865 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |